Predictors of participant engagement and naloxone utilization in a community‐based naloxone distribution program

Authors:
Publisher website
Google Scholar
Abstract
Aims: To describe characteristics of participants and overdose reversals associated with a community‐based naloxone distribution program and identify predictors of obtaining naloxone refills and using naloxone for overdose reversal.Design: Bivariate statistical tests were used to compare characteristics of participants who obtained refills and reported overdose reversals versus those who did not. We fitted multiple logistic regression models to identify predictors of refills and reversals; zero‐inflated multiple Poisson regression models were used to identify predictors of number of refills and reversals.Setting: San Francisco, California, USA.Participants: Naloxone program participants registered and reversals reported from 2010 to 2013.Measurements: Baseline characteristics of participants and reported characteristics of reversals.Findings: A total of 2500 participants were registered and 702 reversals were reported from 2010 to 2013. Participants who had witnessed an overdose [adjusted odds ratio (AOR) = 2.02, 95% confidence interval (CI) = 1.53–2.66; AOR = 2.73, 95% CI = 1.73–4.30] or used heroin (AOR = 1.85, 95% CI = 1.44–2.37; AOR = 2.19, 95% CI = 1.54–3.13) or methamphetamine (AOR = 1.71, 95% CI = 1.37–2.15; AOR = 1.61, 95% CI = 1.18–2.19) had higher odds of obtaining a refill and reporting a reversal, respectively. African American (AOR = 0.63, 95% CI = 0.45–0.88) and Latino (AOR = 0.65, 95% CI = 0.43–1.00) participants had lower odds of obtaining a naloxone refill, whereas Latino participants who obtained at least one refill reported a higher number of refills [incidence rate ratio (IRR) = 1.33 (1.05–1.69)].Conclusions: Community naloxone distribution programs are capable of reaching sizeable populations of high‐risk individuals and facilitating large numbers of overdose reversals. Community members most likely to engage with a naloxone program and use naloxone to reverse an overdose are active drug users.
Funding Information
  • National Institutes of Health (1R03DA038084)

This publication has 25 references indexed in Scilit: